ESR1 and melanoma: Notably, we demonstrate, in line with what would be expected for a primary cholesterol metabolite, that acute exposure to 27HC inhibits the growth of cancer cells (breast cancer and melanoma were studied) consistent with its known ER-independent pharmacology.